![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.10 | -4.88% | 1.95 | 1.90 | 2.00 | 2.05 | 1.95 | 2.05 | 1,899,144 | 14:14:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.37 | 15.12M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/11/2019 13:19 | A close above 185.5p is interesting A close above 190p opens the way to break to fresh highs | ![]() ny boy | |
21/11/2019 11:44 | Its typical AIM. The share price is "made up" by the intermediaryIn the development phase they inflate the share price based on what the company could be potentially. Punters get carried away......Then before the potential is likely to be realised they drop the share price and base it on fundamentals......an | ![]() kop202 | |
21/11/2019 11:33 | MMs seem very twitchy this morning.....which is unusual here! | ![]() nobbygnome | |
21/11/2019 11:12 | Anyone else remember The Black Prince aka Colin Blackburn, and Shield's glory days, when we made out like bandits? | ![]() wantage | |
21/11/2019 11:07 | The madness is that the market cap now is only about £40 million higher (allowing for a small increase in no of shares following a fund raising a few years ago) than after the floatation in 2015. If you think how far the company has progressed Feraccru since then, that statistic is clearly completely and utterly ridiculous. Sometimes you could say it is better to travel in hope than arrive but in this case that is definitely not applicable. The company has delivered several positive trial results including the non inferiority study with the iv treatment, a sales partner in Europe, most importantly approval with a broad label by the FDA and about to deliver licensing deals in the US and China. Madness is the word! | ![]() nobbygnome | |
21/11/2019 11:00 | Let’s see if it lasts the day | ![]() crankyman | |
21/11/2019 10:33 | A breach of the previous high of 195p would be highly significant because above that is all blue sky (obviously)! | ![]() nobbygnome | |
21/11/2019 10:22 | Yes Nobby, possibly a significant moment after a long period of tight consolidation Difficult to keep a major US commercialization deal watertight imo | ![]() ny boy | |
21/11/2019 09:51 | Good timing for my buys today and earlier in the week😜. A leak perhaps that a deal is imminent..... It will be interesting to see what happens the rest of today. | ![]() nobbygnome | |
21/11/2019 09:32 | Looks like there are stirrings of a rise this morning. Finncap have gone on the bid aggressively which usually presides a rise. Consequently I have picked up a few more via Spreadbet..... | ![]() nobbygnome | |
20/11/2019 20:50 | Nelly and his hundred other shares on every board he visits! | ![]() arab3 | |
20/11/2019 20:48 | nellyb...Because it’s more likely investors will make more money than in VRS, I still get PM’s from other advfn members thanking me for bringing it to their attention in the 50-60p’s! | ![]() ny boy | |
20/11/2019 12:27 | DEFINITION of Close Period The close period is the time period between the completion of a listed company's financial results and the announcing of these results to the public. Not sure it applies here? | ![]() ny boy | |
20/11/2019 12:01 | Yes, you could be right but heaviest buys I have seen for a while, reasons to be cheerful imo | ![]() ny boy | |
20/11/2019 12:00 | >> NY boy There is no way it will be Director buys with the ongoing discussions about the imminent licensing deal. They must be in a closed period.... | ![]() nobbygnome | |
20/11/2019 11:57 | Interesting to se the 110k buy; the trades here always intrigue me. It is somewhat surprising that you can apparently easily buy over £200k worth of shares without affecting the price when there doesn't seem to have been many sells recently. | ![]() nobbygnome | |
20/11/2019 11:57 | Another 54,000 + buy, umm me is thinking, are these Director or fund buys, we will soon find out | ![]() ny boy | |
20/11/2019 10:49 | 2000th post! 😁 | ![]() ny boy | |
20/11/2019 10:43 | Had a small top up of 1400 shares. Surprised to only pay £1.834p each. | ![]() rafboy | |
20/11/2019 10:10 | Nice 110,000 buy just in, L2 strengthens, we should be on our way soon! | ![]() ny boy | |
19/11/2019 21:24 | Might be in early January to kick off an exciting decade for STX. Makes no difference to me personally, whether we get a deal this side of the NY, or after.I have been buying since the unloved 30p’s, so I have plenty of patience. | ![]() ny boy | |
19/11/2019 19:57 | Of course both the US and Chinese deal are scheduled for before year end and it would be surprising if we got neither this year. The reality is that they will do a deal in both places because the company can't do it themselves so it is just a matter of time.... And the asset is extremely attractive to the right partner.... | ![]() nobbygnome | |
19/11/2019 18:12 | When does it become material to the share price that we have no deal signed? I assume at year end. If we have no communication yet from management, we can only assume it is on track to be signed by year end. They have been pretty tight on updating the markets but I wonder if another we might see is an update on the partnering. | ![]() crankyman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions